Study aim: Clinical Trial on Diphenhydramine Compound in Covid-19 Treatment Design: This clinical trial is a double-blinded case-control randomized study on 120 patients. Permuted block randomization (...) clinic (chest ct scan and PCR)findings in COViD-19 patients. Mortality and morbidity rate in COViD-19

COVID-19 Design: Prospective clinical trial with parallel randomized control and treatment, open-label (...) to do the study: 60 patients with COVID-19, using block randomization will be divided in to (...) : Patients between 18 and 65 years old who have laboratory confirmed COVID-19 (Corona Virus Disease-19) with

Study aim: Determining the effect of perone position in patients with covid 19 with respiratory failure treated with non-invasive ventilation methods Design: Patients with acute respiratory failure who, despite BIPAP treatment, still have low saturation and a pao2 to FIO2 ratio of less than 300 who are

improvement of hair loss (telogen effluvium) in patients recovered from COVID-19 in Bam Pasteur hospital in (...) Covid 19 disease (positive by PCR test) 2 to 4 months before enrollment Occurrence of persistent and significant hair loss after Covid 19 disease, which according to the diagnosis of a dermatologist has a

Study aim: Investigating the effect of ozone therapy on pulmonary sequels in patients with COVID-19 and the resulting hypoxia Design: Clinical trial with control and intervention groups, with parallel (...) : Filling out the informed consent form; post COVID-19 oxygen dependent patients. Exclusion criteria

Study aim: Determining the effect of bosentan on clinical outcomes of hospitalized patients with COVID-19 infection in comparison with routine protocol Design: Double-blind randomized controlled clinical trial Settings and conduct: In this study, COVID-19 patients, hospitalized in Shahid Mostafa

Study aim: Investigating efficacy and safety of Gluronic acid capsule in patients with moderate to severe COVID-19 Design: a multi-center, randomized, open-labeled, controlled, parallel phase 3 clinical (...) criteria:confirmed diagnosis of COVID-19; the written consciously and freely consent to participate in the study

in patients with Covid 19 Design: Clinical trial with control group, with parallel groups, double-blind, randomized, on 74 patients with Covid 19, Randomization will be allocate Settings and conduct: This study will be performed in 74 patients with Covid-19 in Shahid Jalil Hospital in Yasuj. Patients

secretome in patients with Covid-19 severe pneumonia Design: A clinical trial with the control group, with (...) contamination and then injected intravenously into patients with severe pneumonia caused by Covid-19. Participants/Inclusion and exclusion criteria: Age 40 to 65 years, confirmed pneumonia caused by Covid-19, a

Study aim: Evaluation of the effect of pentoxifylline in the treatment of patients with Covid-19 (...) Hospital, Rasht, on critically ill patients with COVID-19 admitted to the intensive care unit. After (...) for COVID-19 with pentoxifylline for 14 days.Control group: including 10 patients receiving the

process of COVID-19 patients. Design: concealed, randomized, single blinded, phase 2 controlled clinical (...) . Participants/Inclusion and exclusion criteria: All positive COVID-19 patients who have Hb≤9 and at least one of the severe COVID-19 symptoms and are willing to cooperate in this project will be included in the

Study aim: Investigation effect of Internet-based psychoeducational support on perceived stress and caring burden in caregivers of COVID-19 patients. Design: Superiority clinical trial, randomized (...) case of Covid-19. The caregiver should not be a member of the health care system. The caregiver is a

the treatment of outpatients with COVID-19. Design: A two-arm, parallel, randomized, single-blind, controlled clinical trial on 500 COVID-19 outpatients. Random blocks will be used for randomization. Settings and conduct: This study will be performed on outpatients with COVID-19 in an outpatient clinic

Satisfaction of Hospitalized Veterans with Covid-19 Diagnosis. Design: A clinical trial with two intervention (...) veterans with Covid-19. Participants/Inclusion and exclusion criteria: Entry requirements: Be a veteran (...) with Covid. Settings and conduct: This clinical trial will be performed at Sasan Hospital in Tehran

COVID-19 Design: Clinical trial with control group, with parallel groups, no blinding, randomized (...) conduct: A total of 84 patients with COVID-19 virus confirmed by PCR test referred to a private office or (...) . Intervention groups: Intervention group: Patients with covid 19 will consume three cups of green tea daily for

-educational interventions on the perceived stress and resilience of hospitalized patients with COVID-19 (...) were hospitalized in 2 hospitals in Shiraz, after being diagnosed with COVID-19. Patients were (...) over 18 years Willingness to take part in the study Diagnosis of COVID-19 by clinical manifestations

COVID-19,a multicenter randomized clinical trial Design: A clinical trial with a control-group; with (...) Covid-19 patients will be selected and randomly divided into two groups of 28people,so total of 224 (...) Kermanshah.In this study, the samples will be selected from patients with COVID-19 using convenience sampling

-hospitalization and hospitalization patients with symptomatic COVID-19 Design: Clinical trial with control group (...) patients in all four groups with symptomatic Covid-19 virus will be identified with the same .Hesperidin (...) exclusion criteria: Inclusion criteria: COVID-19 virus infection,Clinical symptoms, Lymphocytes less than 15

Study aim: Clinical trial study of the therapeutic effect of Ivermectin in combination with Kaletra and Chloroquine diet in the treatment of Coronavirus patients in 2019 (COVID-19) Design: Clinical trial with control group, parallel group trial, double-blinded, phase 2 on 60 patients. Replacement

COVID-19 Design: This study is a single-center, prospective, randomized, double-blinded, placebo (...) COVID-19. Confirmed diagnosis of COVID-19, with either lung CT-Scan result, which is typical for COVID-19 pulmonary involvement,or RT-PCR confirmation. Less than 7 days have passed since the onset of

COVID-19 infection. Design: This is a single-center, double-blinded, randomized, and controlled (...) with severe COVID-19 infection will be randomly assigned to any of the arms in a blinded manner. The (...) . individuals with severeCOVID-19 symptoms according to Berlin Criteria 6. Hospitalized patients and on

myokin profile of patients improved from COVID-19 Design: Clinical trial has three groups of selected (...) improved female patients from Covid 19 who declare their readiness by recall, 33 people were selected based (...) /Inclusion and exclusion criteria: Inclusion criteria: recovered individuals from COVID-19; Women between the

infections in patients with COVID-19 Design: A randomized controlled trial with parallel groups, single (...) : This study was performed in the inpatient wards of Covid-19 patients. All patients who have been definitively diagnosed with Covid-19 by a positive PCR test and who do not have symptoms of lower respiratory

and hospitalization of patients with COVID-19. Design: A randomized open-label (without-blinding (...) the age range of 40-80 years, weighing more than 50 kg, definitive infection with Covid 19, being in (...) clinical trial study was performed on 150 eligible patients with QUID-19, referring to Amin and Al-Zahra

Study aim: Determining the effect of designed care program in children with coronary heart disease on the clinical competence of nurses and the severity of the disease in the pediatric intensive care unit of Akbar Mashhad Hospital Design: The control trial is parallel to the control group. In one group of patients, they receive routine nursing care, and in another group, they receive nursing care in accordance with the care package designed by trained nurses. In each group, 22 patients and a total of 44 patients will be included in the study. Settings and conduct: In this study, the control group receives routine nursing care based on experience, etc., and the intervention group receives guided care based on a standardized care package according to specific problems in the clinic. Blinding is not performed and the patient The researcher, nurses, physician in charge of the patient's treatment and the statistical analyst know in which group they are. The study will be performed at the PICU of Akbar Hospital in Mashhad. Participants/Inclusion and exclusion criteria: Children whose RT-PCR test is positive. Age between 0 and 18 years. They are hospitalized in the intensive care unit. Patients who do not want to continue participating in the study or have been discharged before the 6th day of hospitalization have been excluded from the study. Nurses working in the PICU of Akbar Hospital. Intervention groups: Intervention group: will receive clinical care based on a care package designed with standard nursing diagnoses based on print sources of Linda and Dwayne Jazz nursing diagnoses. Control group: will only receive routine ward care. Improving the clinical competence of nurses in accordance with the training is the basis for the implementation of the care package. Main outcome variables: ICU admission, death, and disease severity, clinical qualification